Enhancing Outcomes in COPD Patients Undergoing CABG | News Brief

The use of β-blockers appears to be safe and significantly improves survival at mid-term follow-up among patients with COPD who are undergoing CABG. A comparison study showed that patients receiving β-blockers had a mortality rate of 7.7%, compared with an 18.3% rate for those who did not. Rates of COPD exacerbation were similar for both groups.

Abstract: Annals of Thoracic Surgery, February 2013.

Search
Advertisement

From our CME partner, AKH Inc.

CME: Lipids and Cardiovascular Disease
CME Credit: 1.0 hour activity

The content of this activity was initially presented live at the 2014 ISSFAL Congress held in Stockholm, Sweden.  Topics Include Mediterranean Diet, Milk Fat Globule Membrane (MFGM), DHA Fatty Acid, and Omega-3 Index in Heart Failure Patients.

eMedia - Surgery
Facebook

 

 

 

Physician's Weekly for Current Medical News, Events & Issues